Item 2.02  Results of Operations and Financial Condition.
On August 9, 2021 Biohaven Pharmaceutical Holding Company Ltd. (the
"Registrant") issued a press release announcing its financial results for the
quarter ended June 30, 2021. A copy of this press release is furnished herewith
as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

In accordance with General Instruction B.2. of Form 8-K, the information in this
Item 2.02, and Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liability of that section, nor shall it be
deemed incorporated by reference in any of the Registrant's filings under the
Securities Act of 1933, as amended, or the Exchange Act, whether made before or
after the date hereof, regardless of any incorporation language in such a
filing, except as expressly set forth by specific reference in such a filing.


Item 9.01  Financial Statements and Exhibits.



(d) Exhibits

     Exhibit Number*                                       Exhibit Description
           99.1                    Press Release, dated August 9, 2021,

"Biohaven Reports Second Quarter


                                 2021 Financial Results and Recent Business

Developments"



           104                   The cover page of this Current Report on

Form 8-K formatted as Inline


                                 XBRL.

* The XBRL instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.


                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses